Learn how AI is transforming predictions of drug-induced liver injury and aiding drug development for safer therapeutics.

AI across the pharmaceutical ecosystem. The Illumina Billion Cell Atlas is the first tranche of its program to build a 5 billion cell atlas over three years, and will be the most comprehensive map of ...

Machine learning models reveal that histone marks are predictive of gene expression across human cell types and highlight important nuances between natural control and the effects of CRISPR-Cas9-based ...

Illumina unveiled the Billion Cell Atlas, a large‑scale genetic perturbation dataset built with pharma partners to advance AI‑powered drug discovery, target validation, and disease biology.

AI Impact explores why AI security has outgrown human oversight, plus pricing gains, health care insight and key AI moves in ...

Cancer immunity and immunotherapy research increasingly recognizes that chronic inflammation is a major driver of tumorigenesis, yet the complex and dynamic ...

Explore the potential of heart organoids in understanding cardiac disorders and developing new treatment methods.

Stress during pregnancy such as gut changes or a trigger of the immune system can impact the brain health of the foetus, ...

Organoids have now evolved beyond simple experimental models to become next-generation biological platforms that precisely replicate human organ ...

The field of cancer immunotherapy has achieved remarkable progress, introducing strategies such as immune checkpoint inhibitors and adoptive cell therapies ...

Frost & Sullivan is pleased to announce that BostonGene has been recognized for 2025 Global Technology Innovation Leadership in the ...

Researchers found that brief intense workouts enhance DNA repair in colon cancer cells by altering proteins circulating in ...